<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Preeclampsia.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:18 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1250004">
<meta name="Category" content="Concern">
<meta name="Article" content="Preeclampsia">
<title>Preeclampsia-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Preeclampsia</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Preeclampsia.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Myatt L, Miodovnik M. Prediction of preeclampsia. <em>Semin Perinatol</em>
1999;23:45&#8211;57.</li>

<li class="Ref">Smith GN, Walker M, Tessier JL, Millar KG. Increased incidence of preeclampsia
in women conceiving by intrauterine insemination with donor versus partner sperm for treatment
of primary infertility. <em>Am J Obstet Gynecol</em> 1997;177:455&#8211;8.</li>

<li class="Ref">Rey E, LeLorier J, Burgess E, et al. Report of the Canadian Hypertension
Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in
pregnancy. <em>CMAJ</em> 1997;157:1245&#8211;54.</li>

<li class="Ref">Rath W Z. Treatment of hypertensive diseases in pregnancy&#8212;general
recommendations and long-term oral therapy. <em>Geburtshilfe Neonatol</em>
1997;201:240&#8211;6 [in German].</li>

<li class="Ref">Myatt L, Miodovnik M. Prediction of preeclampsia. <em>Semin Perinatol</em>
1999;23:45&#8211;57.</li>

<li class="Ref">Sibai B. Prevention of preeclampsia: a big disappointment. <em>Am J Obstet
Gynecol</em> 1998;179:1275&#8211;8 [review].</li>

<li class="Ref">Mounier-Vehier C, Equine O, Valat-Rigot AS, et al. Hypertensive syndromes in
pregnancy. Physiopathology, definition and fetomaternal complications. <em>Presse Med</em>
1999;28:880&#8211;5 [in French].</li>

<li class="Ref">Mounier-Vehier C, Equine O, Valat-Rigot AS, et al. Hypertensive syndromes in
pregnancy. Physiopathology, definition and fetomaternal complications. <em>Presse Med</em>
1999;28:880&#8211;5 [in French].</li>

<li class="Ref">Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia
in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. <em>
Am J Obstet Gynecol</em> 1997;177:1003&#8211;10.</li>

<li class="Ref">Persson B, Hanson U. Neonatal morbidities in gestational diabetes
mellitus<em>. Diabetes Care</em> 1998;Suppl 2:B79&#8211;84.</li>

<li class="Ref">Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become
pre-eclampsia? <em>Br J Obstet Gynaecol</em> 1998;105:1177&#8211;84.</li>

<li class="Ref">Myatt L, Miodovnik M. Prediction of preeclampsia. <em>Semin Perinatol</em>
1999;23:45&#8211;57.</li>

<li class="Ref">Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia
in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. <em>
Am J Obstet Gynecol</em> 1997;177:1003&#8211;10.</li>

<li class="Ref">Myatt L, Miodovnik M. Prediction of preeclampsia. <em>Semin Perinatol</em>
1999;23:45&#8211;57.</li>

<li class="Ref">Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation may
help. <em>Medscape Womens Health</em> 1997;2:5.</li>

<li class="Ref">Mikhail MS, Anyaegbunam A, Garfinkel D, et al. Preeclampsia and antioxidant
nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol and beta
carotene in women with preeclampsia. <em>Am J Obstet Gynecol</em> 1994;171:150&#8211;7.</li>

<li class="Ref">Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of
severe pre-eclampsia: an explanatory randomised controlled trial. <em>Br J Obstet
Gynaecol</em> 1997;104:689&#8211;96.</li>

<li class="Ref">Valsecchi L, Fausto A, Grazioli V. Severe preeclampsia and antioxidant
nutrients. <em>Am J Obstet Gynecol</em> 1995;173:673 [letter].</li>

<li class="Ref">Bianco A, Stone J, Lynch L, et al. Pregnancy outcome at age 40 and older. <em>
Obstet Gynecol</em> 1996;87:917&#8211;22.</li>

<li class="Ref">Marcoux S, Berube S, Brisson C, Mondor M. Job strain and pregnancy-induced
hypertension. <em>Epidemiology</em> 1999;10:376&#8211;82.</li>

<li class="Ref">Wergeland E, Strand K. Work pace control and pregnancy health in a
population-based sample of employed women in Norway. <em>Scand J Work Environ Health</em>
1998;24:206&#8211;12.</li>

<li class="Ref">Mounier-Vehier C, Equine O, Valat-Rigot AS, et al. Hypertensive syndromes in
pregnancy. Physiopathology, definition and fetomaternal complications. <em>Presse Med</em>
1999;28:880&#8211;5 [in French].</li>

<li class="Ref">Rath W Z. Treatment of hypertensive diseases in pregnancy&#8212;general
recommendations and long-term oral therapy. <em>Geburtshilfe Neonatol</em>
1997;201:240&#8211;6 [in German].</li>

<li class="Ref">Rey E, LeLorier J, Burgess E, et al. Report of the Canadian Hypertension
Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in
pregnancy. <em>CMAJ</em> 1997;157:1245&#8211;54.</li>

<li class="Ref">Sibai BM, Frangieh AY. Management of severe preeclampsia. <em>Curr Opin Obstet
Gynecol</em> 1996;8(2):110&#8211;3.</li>

<li class="Ref">Franx A, Steegers EA, de Boo T, et al. Sodium-blood pressure interrelationship
in pregnancy. <em>J Hum Hypertens</em> 1999;13:159&#8211;66.</li>

<li class="Ref">Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension
Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive
disorders in pregnancy. <em>CMAJ</em> 1997;157:907&#8211;19.</li>

<li class="Ref">Williams MA, King IB, Sorensen TK, et al. Risk of preeclampsia in relation to
elaidic acid (trans fatty acid) in maternal erythrocytes. <em>Gynecol Obstet Invest</em>
1998;46:84&#8211;7.</li>

<li class="Ref">Wergeland E, Strand K. Work pace control and pregnancy health in a
population-based sample of employed women in Norway. <em>Scand J Work Environ Health</em>
1998;24:206&#8211;12.</li>

<li class="Ref">Marcoux S, Berube S, Brisson C, Mondor M. Job strain and pregnancy-induced
hypertension. <em>Epidemiology</em> 1999;10:376&#8211;82.</li>

<li class="Ref">Katz VL, Ryder RM, Cefalo RC, et al. A comparison of bed rest and immersion
for treating the edema of pregnancy. <em>Obstet Gynecol</em> 1990;75:147&#8211;51.</li>

<li class="Ref">Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment
needing more careful evaluation. <em>Lancet</em> 1999;354:1229&#8211;33 [review].</li>

<li class="Ref">Hojo M, August P. Calcium metabolism in normal and hypertensive pregnancy.
<em>Semin Nephrol</em> 1995;15:504&#8211;11 [review].</li>

<li class="Ref">Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation may
help. <em>Medscape Womens Health</em> 1997;2:5.</li>

<li class="Ref">Moutquin JM, Garner PR, Burrows RF, et. al. Report of the Canadian
Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of
hypertensive disorders in pregnancy. <em>CMAJ</em> 1997;157:907&#8211;19.</li>

<li class="Ref">Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent
preeclampsia. <em>N Engl J Med</em> 1997;337:69&#8211;76.</li>

<li class="Ref">Belizan JM. Calcium supplementation to prevent hypertensive disorders of
pregnancy. <em>N Engl J Med</em> 1991;325:1399&#8211;405.</li>

<li class="Ref">Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation may
help. <em>Medscape Womens Health</em> 1997;2:5.</li>

<li class="Ref">Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension
Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive
disorders in pregnancy. <em>CMAJ</em> 1997;157:907&#8211;19.</li>

<li class="Ref">Crowther CA, Hiller JE, Pridmore B, et al. Calcium supplementation in
nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia, and
preterm birth: an Australian randomized trial. FRACOG and the ACT study group. <em>Aust N Z J
Obstet Gynaecol</em> 1999;39:12&#8211;8.</li>

<li class="Ref">Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on
pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled
trials. <em>JAMA</em> 1996;275:1113&#8211;7.</li>

<li class="Ref">Belizan JM. Calcium supplementation to prevent hypertensive disorders of
pregnancy. <em>N Engl J Med</em> 1991;325:1399&#8211;405.</li>

<li class="Ref">Herrera JA, Arevalo-Herrera M, Herrera S. Prevention of preeclampsia by
linoleic acid and calcium supplementation: a randomized controlled trial. <em>Obstet
Gynecol</em> 1998;91:585&#8211;90.</li>

<li class="Ref">Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent
preeclampsia. <em>N Engl J Med</em> 1997;337:69&#8211;76.</li>

<li class="Ref">Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on
pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled
trials. <em>JAMA</em> 1996;275:1113&#8211;7.</li>

<li class="Ref">Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent
preeclampsia. <em>N Engl J Med</em> 1997;337:69&#8211;76.</li>

<li class="Ref">Sibai BM. Prevention of preeclampsia: a big disappointment. <em>Am J Obstet
Gynecol</em> 1998;179:1275&#8211;8.</li>

<li class="Ref">Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent
preeclampsia. <em>N Engl J Med</em> 1997;337:69&#8211;76.</li>

<li class="Ref">Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation
reduces the risk of pregnancy-induced hypertension in an Andes population. <em>Br J Obstet
Gynaecol</em> 1989;96:648&#8211;55.</li>

<li class="Ref">Lopez-Jaramillo P, Narvaez M, Felix C, Lopez A. Dietary calcium
supplementation and prevention of pregnancy hypertension. <em>Lancet</em> 1990;335:293.
[letter]</li>

<li class="Ref">Villar J, Repke JT. Calcium supplementation during pregnancy may reduce
preterm delivery in high-risk populations. <em>Am J Obstet Gynecol</em>
1990;163:1124&#8211;31.</li>

<li class="Ref">Belizan JM, Villar J, Gonzalez L. Calcium supplementation to prevent
hypertensive disorders of pregnancy. <em>N Engl J Med</em> 1991;325:1399&#8211;405.</li>

<li class="Ref">Sanchez-Ramos L, Briones DK, Kaunitz AM, et al. Prevention of
pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive
patients. <em>Obstet Gynecol</em> 1994;84:349&#8211;53.</li>

<li class="Ref">DerSimonian R, Levine RJ. Resolving discrepancies between a meta-analysis and
a subsequent large controlled trial. <em>JAMA</em> 1999;282:664&#8211;70 [review].</li>

<li class="Ref">Ritchie LD, King JC. Dietary calcium and pregnancy-induced hypertension: is
there a relation? <em>Am J Clin Nutr</em> 2000;71(5 Suppl):1371&#8211;4S [review].</li>

<li class="Ref">Villar J, Belizan JM. Same nutrient, different hypotheses: disparities in
trials of calcium supplementation during pregnancy. <em>Am J Clin Nutr</em> 2000;71(5
Suppl):1375&#8211;9S [review].</li>

<li class="Ref">NIH Consensus conference. Optimal calcium intake. NIH Consensus Development
Panel on Optimal Calcium Intake. <em>JAMA</em> 1994;272(24):1942[review].</li>

<li class="Ref">Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension
Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive
disorders in pregnancy. <em>CMAJ</em> 1997;157:907&#8211;19.</li>

<li class="Ref">Leeda M, Riyazi N, de Vries JI, et al. Effects of folic acid and vitamin B6
supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal
growth restriction. <em>Am J Obstet Gynecol</em> 1998;179:135&#8211;9.</li>

<li class="Ref">Powers RW, Evans RW, Majors AK, et al. Plasma homocysteine concentration is
increased in preeclampsia and is associated with evidence of endothelial activation. <em>Am J
Obstet Gynecol</em> 1998;179:1605&#8211;11.</li>

<li class="Ref">Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels with
preeclampsia. <em>Obstet Gynecol</em> 1997;90:168&#8211;71.</li>

<li class="Ref">Laivuori H, Kaaja R, Turpeinen U, et al. Plasma homocysteine levels elevated
and inversely related to insulin sensitivity in preeclampsia. <em>Obstet Gynecol</em>
1999;93:489&#8211;93.</li>

<li class="Ref">Sorensen TK, Malinow MR, Williams MA, et al. Elevated second-trimester serum
homocyst(e)ine levels and subsequent risk of preeclampsia. <em>Gynecol Obstet Invest</em>
1999;48:98&#8211;103.</li>

<li class="Ref">Powers RW, Evans RW, Majors AK, et al. Plasma homocysteine concentration is
increased in preeclampsia and is associated with evidence of endothelial activation. <em>Am J
Obstet Gynecol</em> 1998;179:1605&#8211;11.</li>

<li class="Ref">Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the
risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic
review. <em>Placenta</em> 1999;20:519&#8211;29 [review].</li>

<li class="Ref">Sorensen TK, Malinow MR, Williams MA, et al. Elevated second-trimester serum
homocyst(e)ine levels and subsequent risk of preeclampsia. <em>Gynecol Obstet Invest</em>
1999;48:98&#8211;103.</li>

<li class="Ref">Roberts JM. Endothelial dysfunction in preeclampsia. <em>Semin Reprod
Endocrinol</em> 1998;16:5&#8211;15.</li>

<li class="Ref">Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium,
circulating factor(s) and vascular endothelial growth factor. <em>J Soc Gynecol Investig</em>
1999;6:3&#8211;10.</li>

<li class="Ref">Lyall F, Greer IA. The vascular endothelium in normal pregnancy and
pre-eclampsia. <em>Rev Reprod</em> 1996;1:107&#8211;16.</li>

<li class="Ref">Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced
hypertension. <em>Lancet</em> 1994;341:1447&#8211;54.</li>

<li class="Ref">Taylor RN, de Groot CJ, Cho YK, Lim KH. Circulating factors as markers and
mediators of endothelial cell dysfunction in preeclampsia. <em>Semin Reprod Endocrinol</em>
1998;16:17&#8211;31.</li>

<li class="Ref">Leeda M, Riyazi N, de Vries JI, et al. Effects of folic acid and vitamin B6
supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal
growth restriction. <em>Am J Obstet Gynecol</em> 1998;179:135&#8211;9.</li>

<li class="Ref">Wachstein M, Graffeo LW. Influence of Vitamin B6 on the incidence of
preeclampsia. <em>Obstet Gynecol</em> 1956;8:177&#8211;80.</li>

<li class="Ref">Lazebnik N, Kuhnert BR, Kuhnert PM. Zinc, cadmium, and hypertension in
parturient women. <em>J Obstet Gynecol</em> 1989;161:437&#8211;40.</li>

<li class="Ref">Cherry FF, Bennett EA, Bazzano GS, et al. Plasma zinc in hypertension/toxemia
and other reproductive variables in adolescent pregnancy. <em>Am J Clin Nutr</em>
1981;34:2367&#8211;75.</li>

<li class="Ref">Simmer K, Iles CA, James C, Thompson RP. Are iron-folate supplements harmful?
<em>Am J Clin Nutr</em> 1987;45:122&#8211;5.</li>

<li class="Ref">Hunt IF, Murphy NJ, Cleaver AE, et al. Zinc supplementation during pregnancy:
effects on selected blood constituents and on progress and outcome of pregnancy in low-income
women of Mexican descent. <em>Am J Clin Nutr</em> 1984;40:508&#8211;21.</li>

<li class="Ref">Mahomed K, James DK, Golding J, McCabe R. Zinc supplementation during
pregnancy: a double-blind randomised controlled trial. <em>BMJ</em> 1989;299:826&#8211;9.</li>

<li class="Ref">Jonsson B, Hauge B, Larsen MF, Hald F. Zinc supplementation during pregnancy:
a double blind randomised controlled trial. <em>Acta Obstet Gynecol Scand</em>
1996;75:725&#8211;9.</li>

<li class="Ref">Sibai BM. Prevention of preeclampsia: A big disappointment. <em>Am J Obstet
Gynecol</em> 1998;179:1275&#8211;8 [review].</li>

<li class="Ref">Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in
maternal erythrocytes and risk for preeclampsia. <em>Epidemiology</em>
1995;6:232&#8211;7.</li>

<li class="Ref">Laivuori H, Hovatta O, Viinikka L, Ylikorkala O. Dietary supplementation with
primrose oil or fish oil does not change urinary excretion of prostacyclin and thromboxane
metabolites in pre-eclamptic women. <em>Prostaglandins Leukot Essent Fatty Acids</em>
1993;49:691&#8211;4.</li>

<li class="Ref">Onwude JL, Lilford RJ, Hjartardottier H, et. al. A randomised double blind
placebo controlled trial of fish oil in high risk pregnancy. <em>Br J Obstet Gynaecol</em>
1995;109:95&#8211;100.</li>

<li class="Ref">Salvig JD, Olsen SF, Secher NJ. Effects of fish oil supplementation in late
pregnancy on blood pressure: a randomised controlled trial. <em>Br J Obstet Gynaecol</em>
1996;103:529&#8211;33.</li>

<li class="Ref">Tabacova S, Balabaeva L, Little RE. Maternal exposure to exogenous nitrogen
compounds and complications of pregnancy. <em>Arch Environ Health</em>
1997;52:341&#8211;7.</li>

<li class="Ref">Mutlu-Turkoglu U, Ademoglu E, Ibrahimoglu L, et al. Imbalance between lipid
peroxidation and antioxidant status in preeclampsia. <em>Gynecol Obstet Invest</em>
1998;46:37&#8211;40.</li>

<li class="Ref">Mikhail MS, Anyaegbunam A, Garfinkel D, et al. Preeclampsia and antioxidant
nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol and beta
carotene in women with preeclampsia. <em>Am J Obstet Gynecol</em> 1994;171:150&#8211;7.</li>

<li class="Ref">Valsecchi L, Fausto A, Grazioli V. Severe preeclampsia and antioxidant
nutrients. <em>Am J Obstet Gynecol</em> 1995;173:673 [letter].</li>

<li class="Ref">Schiff E, Friedman SA, Stampfer M, et al. Dietary consumption and plasma
concentrations of vitamin E in pregnancies complicated by preeclampsia. <em>Am J Obstet
Gynecol</em> 1996;175:1024&#8211;8.</li>

<li class="Ref">Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the
occurrence of pre-eclampsia in women at increased risk: a randomised trial. <em>Lancet</em>
1999;354:810&#8211;6.</li>

<li class="Ref">Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of
severe pre-eclampsia: an explanatory randomised controlled trial. <em>Br J Obstet
Gynaecol</em> 1997;104:689&#8211;96.</li>

<li class="Ref">Wynn A, Wynn M. Magnesium and other nutrient deficiencies as possible causes
of hypertension and low birth weight. <em>Nutr Health</em> 1988;6:69&#8211;88.</li>

<li class="Ref">Spatling L, Spatling G. Magnesium supplementation in pregnancy: a double-blind
study. <em>Br J Obstet Gynaecol</em> 1988;950:120&#8211;5.</li>

<li class="Ref">Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: a
double-blind randomized controlled clinical trial. <em>Am J Obstet Gynecol</em>
1989;161:115&#8211;9.</li>

<li class="Ref">Standley CA, Whitty JE, Mason BA, Cotton DB. Serum ionized magnesium levels in
normal and preeclamptic gestation. <em>Obstet Gynecol</em> 1997;89:24&#8211;7.</li>

<li class="Ref">Handwerker SM, Altura BT, Altura BM. Ionized serum magnesium and potassium
levels in pregnant women with preeclampsia and eclampsia. <em>J Reprod Med</em>
1995;40:201&#8211;8.</li>

<li class="Ref">Conradt A, Weidinger H, Algayer G. Magnesium deficiency, a possible cause of
pre-eclampsia: reduction of frequency of premature rupture of membranes and premature or
small-for-date deliveries after magnesium supplementation. <em>J Am Coll Nutr</em>
1985;4:321.</li>

<li class="Ref">Spatling L, Spatling G. Magnesium supplementation in pregnancy: a double-blind
study. <em>Br J Obstet Gynaecol</em> 1988;950:120&#8211;5.</li>

<li class="Ref">Wacker J, Fruhauf J, Schulz M, et al. Riboflavin deficiency and preeclampsia.
<em>Obstet Gynecol</em> 2000;96:38&#8211;44.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Preeclampsia.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:18 GMT -->
</html>

